Monisha Singh

Dr. Monisha Singh

Hospital Medicine
2201 Chapel Ave West, 
Cherry Hill, NJ 
2201 Chapel Ave West, 
Cherry Hill, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Monisha Singh is a primary care provider, practicing in Hospital Medicine in Cherry Hill, New Jersey. Her top areas of expertise are Metastatic Insulinoma, Milk-Alkali Syndrome, Hypercalcemia, and Non-Small Cell Lung Cancer (NSCLC).

Her clinical research consists of co-authoring 5 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Touro College Of Osteopathic Medicine
Residency
Jefferson Health NJ
Specialties
Hospital Medicine
Hospital Affiliations
Jefferson Stratford Hospital
Jefferson Washington Township Hospital
Jefferson Cherry Hill Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Provider Partners Health Plan
  • MEDICARE SNP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 4 Less Insurance Carriers -

Locations

Jefferson Cherry Hill Hospital
2201 Chapel Ave West, Cherry Hill, NJ 08002
Other Locations
Jefferson Stratford Hospital
18 East Laurel Road, Stratford, NJ 08084
435 Hurffville-Cross Keys Road, Turnersville, NJ 08012

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized Phase II Trial of Triplet Therapy (A PD-L1 Inhibitor Durvalumab (MEDI4736) in Combination With Olaparib and Cediranib) Compared to Olaparib and Cediranib or Durvalumab (MEDI4736) and Cediranib or Standard of Care Chemotherapy in Women With Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Primary Peritoneal or Fallopian Cancer Who Have Received Prior Bevacizumab
A Randomized Phase II Trial of Triplet Therapy (A PD-L1 Inhibitor Durvalumab (MEDI4736) in Combination With Olaparib and Cediranib) Compared to Olaparib and Cediranib or Durvalumab (MEDI4736) and Cediranib or Standard of Care Chemotherapy in Women With Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Primary Peritoneal or Fallopian Cancer Who Have Received Prior Bevacizumab
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2025
Intervention Type: Procedure, Drug, Biological
Study Drugs: Cediranib Maleate, Durvalumab, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Topotecan Hydrochloride
Study Phase: Phase 2
A Pilot Study of Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention In Women At High Risk Of Breast Cancer
A Pilot Study of Hydroxytyrosol, a Component of Olive Oil for Breast Cancer Prevention In Women At High Risk Of Breast Cancer
Enrollment Status: Completed
Publish Date: October 10, 2023
Intervention Type: Drug
Study Drug: Hydroxytyrosol
Study Phase: Phase 2/Phase 3
Phase II Study of The Efficacy And Safety of Chloroquine (C) in CombinAtion With Taxane or Taxane-like (T) Chemo Agents in The Treatment of Patients With Advanced or Metastatic Breast Cancer Who Have Failed Anthracycline Chemo Base Therapy
Phase II Study of The Efficacy And Safety of Chloroquine (C) in CombinAtion With Taxane or Taxane-like (T) Chemo Agents in The Treatment of Patients With Advanced or Metastatic Breast Cancer Who Have Failed Anthracycline Chemo Base Therapy
Enrollment Status: Completed
Publish Date: January 23, 2023
Intervention Type: Drug
Study Phase: Phase 2
Randomized Open Label PhII Trial of Neoadjuvant Trastuzumab Emtansine(Te) in Combination w/Lapatinib(L) Followed by Abraxane (A) Compared w/Trastuzumab Plus Pertuzumab Followed by Paclitaxel in Her2/Neu Over-Expressed Breast Cancer Patients
Randomized Open Label PhII Trial of Neoadjuvant Trastuzumab Emtansine(Te) in Combination w/Lapatinib(L) Followed by Abraxane (A) Compared w/Trastuzumab Plus Pertuzumab Followed by Paclitaxel in Her2/Neu Over-Expressed Breast Cancer Patients
Enrollment Status: Completed
Publish Date: September 22, 2021
Intervention Type: Drug
Study Phase: Phase 2
Neoadjuvant Phase II Study Of Everolimus Plus Cisplatin In Triple Negative Breast Cancer Patients With Residual Disease After Standard Chemotherapy
Neoadjuvant Phase II Study Of Everolimus Plus Cisplatin In Triple Negative Breast Cancer Patients With Residual Disease After Standard Chemotherapy
Enrollment Status: Completed
Publish Date: July 20, 2021
Intervention Type: Drug
Study Phase: Phase 2
Phase Ib Trial of Trastuzumab Emtansine In Combination With Lapatinib Plus Abraxane In Metastatic Her 2 Neu Over-Expressed Breast Cancer Patients
Phase Ib Trial of Trastuzumab Emtansine In Combination With Lapatinib Plus Abraxane In Metastatic Her 2 Neu Over-Expressed Breast Cancer Patients
Enrollment Status: Completed
Publish Date: April 16, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 5 Less Clinical Trials

5 Total Publications

Rethinking the second act: the case for checkpoint inhibitor rechallenge in advanced endometrial cancer.
Rethinking the second act: the case for checkpoint inhibitor rechallenge in advanced endometrial cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 21, 2025
Similar Doctors
Expertise in
53
conditions
Dr. Ricki S. Carroll
Hospital Medicine | Pediatrics
Expertise in
53
conditions
Dr. Ricki S. Carroll
Hospital Medicine | Pediatrics

The Nemours Foundation

1600 Rockland Rd, 
Wilmington, DE 
 (26.2 miles away)
302-651-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Ricki Carroll is a Hospital Medicine specialist and a Pediatrics provider in Wilmington, Delaware. Dr. Carroll is highly rated in 53 conditions, according to our data. Her top areas of expertise are Thanatophoric Dysplasia, Spondyloepiphyseal Dysplasia, Diastrophic Dysplasia, Acromicric Dysplasia, and Osteotomy. Dr. Carroll is currently accepting new patients.

Expertise in
4
conditions
Dr. Varun Aggarwal
Hospital Medicine
Expertise in
4
conditions
Dr. Varun Aggarwal
Hospital Medicine

Methodist Hospital

2301 S Broad St, 
Philadelphia, PA 
 (14.0 miles away)
215-952-9434
Experience:
17+ years
Languages Spoken:
English
See accepted insurances

Varun Aggarwal is a primary care provider, practicing in Hospital Medicine in Philadelphia, Pennsylvania. Dr. Aggarwal has been practicing medicine for over 17 years is highly rated in 4 conditions, according to our data. His top areas of expertise are Congenital Cardiovascular Shunt, Coronary Artery Fistula, Pulmonary Atresia, Stent Placement, and Kidney Transplant.

Expertise in
25
conditions
Dr. Nauman Ahmad
Hospital Medicine
Expertise in
25
conditions
Dr. Nauman Ahmad
Hospital Medicine

TeamHealth Hospitalists

1 Riverview Plaza, 2 North, 
Red Bank, NJ 
 (11.1 miles away)
732-673-0286
Languages Spoken:
English
See accepted insurances

Nauman Ahmad is a primary care provider, practicing in Hospital Medicine in Red Bank, New Jersey. Dr. Ahmad is highly rated in 25 conditions, according to our data. His top areas of expertise are Chemosis, Pneumonia, Sepsis, Cataract Removal, and Hernia Surgery.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Singh's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile